Home › Geographic Atrophy › California › Sacramento
Geographic Atrophy clinical trials in Sacramento, CA
5 studies for Geographic Atrophy are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
RecruitingPhase 1/2
- Retinal Consultants - Sacramento - Parkcenter Drive- Site Number : 8400054, Sacramento
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- UC Davis Health Eye Center, Sacramento
- Vrmg Inc, Sacramento
- Retinal Consultants Medical Group (RCMG) - Greenback Lane Retina Center, Sacramento
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
RecruitingPhase 2
- Retinal Consultants Medical Group, Sacramento
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- Retinal Consultants Medical Group, Sacramento
Phase 1 Study of C.001 in Retinal Degeneration
RecruitingPhase 1
- Retinal Consultants Medical Group, Sacramento
Geographic Atrophy trials in other cities
- Reno, NV8 studies
- Dallas, TX8 studies
- Austin, TX7 studies
- Santa Monica, CA7 studies
- Cleveland, OH6 studies
- Naperville, IL6 studies
- The Woodlands, TX6 studies
- Baltimore, MD6 studies
- Houston, TX6 studies
- St. Louis, MO5 studies
- Washington, DC5 studies
- Erie, PA5 studies
Other studies in Sacramento
- Non-Small Cell Lung Cancer29 studies
- Lung Cancer22 studies
- Breast Cancer20 studies
- Prostate Cancer19 studies
- Metastatic Cancer16 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure12 studies
- Pancreatic Cancer12 studies
- Cancer (all types)11 studies
- Colon Cancer11 studies
- Bladder Cancer10 studies
- Colorectal Cancer10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.